Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-1-28
|
pubmed:abstractText |
This study examined the mechanisms underlying the intense activation of HIV-1-specific B cells observed in peripheral blood of HIV-1-infected subjects. Spontaneous in vitro synthesis of anti-HIV-1 antibodies, as well as total Ig production, were dramatically reduced by accessory cell, but not T cell removal. This fall was counteracted by addition of rIL-6, but not other cytokines, to monocyte-depleted cultures; moreover, antisera against IL-6 suppressed spontaneous anti-HIV-1 antibody synthesis in a dose-dependent manner. Although IL-6 apparently sustained HIV-1-specific B cell activation, no increase in serum IL-6 levels was observed; PBMC from seropositive subjects did not produce increased amounts of IL-6 in vitro, compared to seronegative controls, both spontaneously and in the presence of LPS stimulation; finally, no constitutive expression of IL-6 gene could be documented in freshly isolated PBMC. These findings indicate that IL-6 may play a central role in HIV-1-specific B cell activation in seropositive patients, and further stress the importance of this cytokine during HIV-1 infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
146
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
57-62
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1984452-B-Lymphocytes,
pubmed-meshheading:1984452-Blotting, Northern,
pubmed-meshheading:1984452-Cell Communication,
pubmed-meshheading:1984452-Cytokines,
pubmed-meshheading:1984452-Gene Expression,
pubmed-meshheading:1984452-HIV,
pubmed-meshheading:1984452-HIV Antibodies,
pubmed-meshheading:1984452-HIV Infections,
pubmed-meshheading:1984452-Humans,
pubmed-meshheading:1984452-Interleukin-1,
pubmed-meshheading:1984452-Interleukin-2,
pubmed-meshheading:1984452-Interleukin-4,
pubmed-meshheading:1984452-Interleukin-6,
pubmed-meshheading:1984452-Lymphocyte Activation,
pubmed-meshheading:1984452-RNA, Messenger
|
pubmed:year |
1991
|
pubmed:articleTitle |
B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement.
|
pubmed:affiliation |
Institute of Oncology, University of Padua, Italy.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|